This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sarepta Therapeutics Inc (SRPT)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 80.30M 73.55M 256.96M 187.66M
Receivables 3.98M 2.42M 3.53M 4.71M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 14.27M 35.04M 3.06M 1.53M
Total Current Assets 224.54M 247.80M 270.81M 193.91M
Property, Plant & Equipment, Gross 61.94M 58.40M 32.38M 20.11M
Accumulated Depreciation & Depletion 24.59M 19.90M 17.33M 16.71M
Property, Plant & Equipment, Net 37.34M 38.50M 15.05M 3.40M
Intangibles 6.64M 5.89M 5.04M 4.91M
Other Non-Current Assets 5.25M 2.85M 672.00K 2.77M
Total Non-Current Assets 49.24M 47.24M 20.76M 11.09M
Liabilities & Shareholder Equity
Total Assets 273.78M 295.03M 291.57M 204.99M
Accounts Payable 20.23M 12.41M 17.63M 7.53M
Short Term Debt 5.94M 98.00K 92.00K 89.00K
Other Current Liabilities 1.27M 1.19M 9.89M 65.22M
Total Current Liabilities 62.29M 36.87M 35.97M 78.89M
Long Term Debt 14.97M 3.74M 1.58M 1.67M
Deferred Income Taxes 6.17M 6.78M 6.83M 0.00
Other Non-Current Liabilities 0.00 0.00 0.00 760.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 21.14M 10.51M 8.41M 2.43M
Total Liabilities 83.44M 47.38M 44.38M 81.31M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 190.35M 247.65M 247.19M 123.68M
Common Par 5.00K 4.00K 4.00K 3.00K
Additional Paid In Capital 1.09B 926.77M 790.42M 554.93M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -899.05M -679.02M -543.24M -431.25M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -111.00K -95.00K 0.00 0.00
Total Capitalization 205.32M 251.39M 248.77M 125.35M
Total Equity 190.35M 247.65M 247.19M 123.68M
Total Liabilities & Stock Equity 273.78M 295.03M 291.57M 204.99M
Total Common Shares Outstanding 45.63M 41.31M 37.75M 31.70M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 42.29M 40.03M 33.85M 23.60M
Diluted Weighted Shares Outstanding 42.29M 40.03M 33.85M 23.60M
Number of Employees 270 204 146 103
Number of Part-Time Employees 0 0 0 0
SRPT News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

SRPT Sarepta Therapeutics Inc

Chart of SRPT

Analysts Ratings for SRPT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 4 5 5
Moderate Buy 1 1 1 1
Hold 5 6 6 6
Moderate Sell 1 0 0 0
Strong Sell 4 1 0 0
GET SRPT ANALYST REPORT

SRPT Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs